Product Images Gadobutrol
View Photos of Packaging, Labels & Appearance
- structure - gad02 0000 01
- Fresenius Kabi Logo - gad02 0000 02
- PRINCIPAL DISPLAY PANEL – 2 mmol/2 mL - Carton - gad02 0000 03
- PRINCIPAL DISPLAY PANEL – 2 mmol/2 mL – Vial Label - gad02 0000 04
- PRINCIPAL DISPLAY PANEL – 7.5 mmol/7.5 mL - Carton - gad02 0000 05
- PRINCIPAL DISPLAY PANEL – 7.5 mmol/7.5 mL – Vial Label - gad02 0000 06
- PRINCIPAL DISPLAY PANEL – 10 mmol/10 mL - Carton - gad02 0000 07
- PRINCIPAL DISPLAY PANEL – 10 mmol/10 mL – Vial Label - gad02 0000 08
- PRINCIPAL DISPLAY PANEL – 15 mmol/15 mL - Carton - gad02 0000 09
- PRINCIPAL DISPLAY PANEL – 15 mmol/15 mL – Vial Label - gad02 0000 10
Product Label Images
The following 10 images provide visual information about the product associated with Gadobutrol NDC 65219-281 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL – 2 mmol/2 mL - Carton - gad02 0000 03

Gadobutrol Injection is a sterile solution used for intravenous administration. Each mL of this solution contains 604.72mg of gadobutrol and is recommended to be used at a dosage of 0.1 mL/kg 3x2mL. It is the active ingredient in the solution, which also contains calcobutrol sodium, trometamol, hydrochloric acid, and water. The solution does not contain any antimicrobial preservative. The usual dosage is mentioned in the package insert. This solution is stored at a controlled room temperature of 25°C (77°F), and excursions up to 15°C to 30°C (59° to 86°F) are permitted. The product is manufactured in China for H\'] FRESENIUS KABI, located at Lake Zurich, L 60047. The solution is supplied in single-dose vials, and unused portions must be discarded.*
PRINCIPAL DISPLAY PANEL – 2 mmol/2 mL – Vial Label - gad02 0000 04

This is a description of a medication called Gadobutrol Injection. The suggested dose is 0.1 mL/kg and 2mL. Any unused portion should be discarded, and it is only available via prescription (Rxonly). It is manufactured by Fresenis and the product is a single dose vial. The text also indicates the lot number and expiration date. It should be administered intravenously. However, the production site is not in a readable text format.*
PRINCIPAL DISPLAY PANEL – 7.5 mmol/7.5 mL - Carton - gad02 0000 05

Gadobutrol injection is a sterile solution to be administered intravenously. The active ingredient in each mL is 604.72 mg gadobutrol, and other ingredients include calcobutrol sodium, trometamol, hydrochloric acid, and water for injection. This injection does not contain any antimicrobial preservative. The usual dosage is as per the package insert, and the recommended dose is 0.1 mL/kg. Each single-dose vial contains 7.5 mmol of gadobutrol (1 mmol/mL). It should be stored at room temperature (25°C) and discarded if not used. The manufacturer is H'h Frensenius Kabi and it is a product of China.*
PRINCIPAL DISPLAY PANEL – 7.5 mmol/7.5 mL – Vial Label - gad02 0000 06

Dose: 0.1 mL/kg 7.5mL. NDC 65219-281-03 is a single-dose vial of Gadobutrol Injection, a sterile solution that should be discarded after use. The product is manufactured in China and contains 1 mmol/mL. The rest of the text is not readable.*
PRINCIPAL DISPLAY PANEL – 10 mmol/10 mL - Carton - gad02 0000 07

This is the description of a medication called Gadobutrol injection. It is packaged as 10 single-use vials containing 604.72 mg of Gadobutrol per mL, with additional active ingredients, including Calcobutrol sodium and Trometamol. Gadobutrol injection does not contain any antimicrobial preservative. The medication is administered intravenously. It should be stored at room temperature, with permitted excursions. The product is manufactured in China. The information provided also contains instructions for use, dosage, and important warnings.*
PRINCIPAL DISPLAY PANEL – 10 mmol/10 mL – Vial Label - gad02 0000 08

This is a product label for a single-dose vial of Gadobutrol Injection. The vial contains 10mmol/1.0mL of a sterile solution intended for intravenous administration. The recommended dose is 0.1 mL/kg. The National Drug Code (NDC) is 65219-281-08 and it is available only by prescription. The lot number and expiration date are not visible in the provided text.*
PRINCIPAL DISPLAY PANEL – 15 mmol/15 mL - Carton - gad02 0000 09

This text describes the composition, dosage and storage instructions for Gadobutrol injection. Each mL of the injection contains 604.72 mg of Gadobutrol as the active ingredient along with other compounds. The medication has no antimicrobial preservative and the usual dosage should be seen in the package insert. The medication should be stored at a temperature of 25°C, with excursions permitted to 15°to 30°C. The text also lists the manufacturer and the product details. It states that the product is for intravenous administration, is a sterile solution and is available in single-dose vials. The text also provides dosage instructions and lot and expiry details.*
PRINCIPAL DISPLAY PANEL – 15 mmol/15 mL – Vial Label - gad02 0000 10

This is a description of a medication, specifically Gadobutrol Injection. It comes in a single-dose vial with a volume of 15mL and a concentration of 1 mmol/mL. The medication is intended for intravenous administration only, and any unused portions should be discarded. The solution is sterile, and it is manufactured by Fresenius Kabi for distribution in Lake Zurich, IL. The lot number and expiration date are provided as 26DUA01 and are accompanied by a National Drug Code (NDC) number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.